Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Patients and Healthcare Professionals Concerned About Prescription Opioid Misuse and Addiction, but Survey Reveals Knowledge Gap on Minimizing Risks & Misuse

WebMD and Medscape release new data on consumer and healthcare professionals' awareness of issues surrounding opioid use as part of commitment to White House effort

Nearly three-quarters of physicians report prescribing fewer opioids due to increased abuse, misuse and diversion

Majority of healthcare professionals (91%) tell patients how and when to take opioids, yet only 55% discuss safe storage and disposal

Consumers less likely than healthcare professionals to think that misuse, addiction, and prescription-sharing occurs with prescription opioid use


News provided by

WebMD

Jan 05, 2016, 08:05 ET

Share this article

Share toX

Share this article

Share toX

Opioid Misuse & Addiction. Where's the Disconnect?
Opioid Misuse & Addiction. Where's the Disconnect?
Speed
Speed
Quality
Quality
WebMD logo
WebMD logo
Medscape Logo
Medscape Logo

NEW YORK, Jan. 5, 2016 /PRNewswire/ -- WebMD Health Corp. (NASDAQ: WBMD), the leading source of health information, today announced the results of a new survey showing that consumers and healthcare professionals (HCPs) share concerns about prescription opioid misuse, addiction, and the potential for the drugs to fall into the wrong hands – but fewer than 3 in 5 patients and HCPs discuss safe storage and disposal of the medications, potentially fueling the problem.

The survey, conducted by WebMD and Medscape, is part of a White House initiative calling on public and private organizations, including WebMD and Medscape, to address the issue of prescription drug abuse and heroin use.  The survey found that 88% of healthcare professionals prescribe opioids, (e.g., hydrocodone, oxycodone), mirroring national statistics showing the number of prescriptions in the U.S. skyrocketing from 76 million in 1991 to nearly 207 million in 2013.   This increase, coupled with the survey's finding that 42% of patients who have used an opioid in the past three years say they store their leftover opioids for future use, points toward the development of a national inventory of prescription pain medications in America's medicine cabinets.  With the drugs on hand, there is concern that they may be shared or used for purposes other than prescribed.  According to the National Institute on Drug Abuse (NIDA), the number of people dying from prescription opioid pain reliever overdoses has more than tripled in the past 30 years.    

The new survey data reveals both knowledge gaps and discrepancies, including a disconnect in patient-physician communication about addiction risks, and a lack of patient awareness about appropriate storage and disposal.

Conducted between November and December, the survey obtained responses from 1,887 consumers who visited the desktop or mobile WebMD site, and 1,513 U.S. clinicians who are currently active on Medscape, including physicians, nurse practitioners and physician assistants.

To read the full 2015 WebMD/Medscape Opioid Survey executive summary, providing additional data and expert perspectives, visit:

http://www.medscape.com/viewarticle/856589

Or

http://www.webmd.com/mental-health/addiction/news/20151229/opioid-survey

To view a video further showcasing the survey data, visit: http://videostorage.prnewswire.com/storage2/download/77225_Opioid_1080_MP4.zip 

Patterns of Opioid Prescribing and Use
The majority of consumers (63%) have used a prescription opioid in their lifetime, with more than a third (35%) in the past three years. While the majority of healthcare professionals (88%) have prescribed an opioid, physicians' willingness to prescribe has declined, with 69% reporting reduced opioid prescribing (a reduction borne out in IMS Health data, which revealed a decline in opioid prescriptions by 2 million in 2012 and 10 million fewer in 2013). 

Patients who used a prescription opioid in the past three years say they received them from their primary care provider (42%), a specialist (41%), or a dental/oral surgeon (14%).  Twenty-three percent received the prescription from a pain medicine specialist and another 27% of patients received the prescription after a hospital visit (including ER).

Most of the respondents who reported taking opioids in the past three years did so  to manage short-term (acute) pain (43%) or for other types of pain (36%), such as a surgical or dental procedure. Still, a significant number of patients – more than 1 in 4 (28%) – take them to relieve chronic pain.

Experience with Alternative Treatments
Recognizing the potential for abuse or addiction, nearly all patients (92%) who have used opioids in the past three years have tried alternative pain approaches, including over-the-counter medication (81%), topical prescriptions (36%), and alternative medicine (25%), such as acupuncture and herbal remedies. However, only 1 in 4 (24%) report any of these options was effective.

Side Effects and Safe Storage:  Gaps in Patient-Physician Communication
While the majority of HCPs and patients who took prescription opioids in the past three years do discuss proper usage of opioids and their side effects,  gaps exist between physicians' self-reported rates of discussion and the rates at which patients say they receive information:

  • Patients and professionals say they have discussed "how and when to take the medication" (92%, respectively)
  • A substantially higher number of HCPs report discussing the following topics, compared to the number of patients who report receiving that information – highlighting a disconnect between what HCPs believe they are sharing with patients and what patients report receiving:
    • Side effects (93% of HCPs vs. 81% of patients)
    • Risks/concerns about abuse and addiction (80% vs. 71%)
    • Not sharing the medications (70% vs. 62%)
  • Further, only about half of both HCPs (55%) and patients (57%) report discussing safe storage and disposal of the medications, which are lower proportions than their discussions about risks and how to use the medications

Importantly, while more than 4 in 10 patients think that other patients are misusing or abusing opioids, there seems to be a disconnect between overall perceived risks and the possibility of personal involvement. For example, while only 2% of patients claimed to do any sharing of their own prescribed opioids, 42% believe opioid sharing is occurring. 

Abuse and Misuse:  HCP Concerns
HCPs are nearly unanimous in their concern about opioid misuse (99% concerned). Patients report a lower level of concern than HCPs on some of the the following topics:   

  • Abuse (purposeful use other than as prescribed): 52% of HCPs vs. 46% of patients
  • Addiction: 54% of HCPs vs. 6% of patients
  • Sharing prescriptions: 55% of HCPs vs. 42% of patients
  • Prescription medications falling into the wrong hands: 36% of HCPs vs. 36% of patients
  • Leading to the use of stronger drugs, such as morphine or heroin: 38% of HCPs vs. 38% of patients

HCPs also express concerns about how patients use opioids, with the majority believing that patients "frequently" take more than prescribed (66%) and/or take the medication for purposes other than those prescribed (52%). A sizeable proportion of HCPs (38%) also believe that backlash against opioid analgesic prescribing – and increased regulation around these medications – has diverted abusers to stronger compounds such as morphine and heroin.

The Dangers of a National "Public Inventory"
Of those patients who have taken an opioid in the past three years, more than 4 in 10 (42%) say they store the leftovers for future use, contributing to a large "public inventory." With more than 100 million opioid prescriptions written during the past 20 years, this practice translates into a large number of unused opioids in the nation's medicine cabinet – presenting a greater opportunity for misuse and abuse by anyone for whom the drugs were not prescribed.  Only 23% of patients report returning unused opioids to pharmacies that offer disposal programs.

Quote
Michael W. Smith, MD, MBA, Medical Director and Chief Medical Editor, WebMD

  • "With opioid prescriptions and overdose-related deaths affecting Americans at alarming rates, understanding patient and physician perceptions of risk and appropriate use play an important role in helping to reduce misuse, addiction and diversion. Healthcare professionals need to revisit their approach to discussing addiction risks and proper storage and disposal with patients to ensure guidance is clear; similarly, patients need to be aware of all of the potential risks associated with these powerful drugs, including abuse, addiction, and having the drugs fall into the wrong hands."

About the WebMD Opioids Use and Addiction Survey (Patient Audience)
WebMD's Opioids Use and Addiction Survey was completed by 1,887 random U.S. desktop and mobile WebMD site visitors from November 18 - 25, 2015.  The sample represents the WebMD.com online population with a margin of error of ± 2.25% at a 95% confidence level, using a point estimate (a statistic) of 50%, given a binomial distribution. The subsample size for those who used a prescription opioid in the past 3 years is 659.

About the Medscape Opioids Use and Addiction Survey (Professional Audience)
Medscape's Opioids Use and Addiction Survey was completed by 1,513 U.S. clinicians who are currently active on Medscape. The largest group of respondents was physicians (n=832), followed by nurse practitioners (491) and physician assistants (190). The survey was fielded November 20 to December 8, 2015, via email invitation. The sample represents active Medscape clinicians at the 95% confidence interval with a margin of error of ± 2.52%, using a point estimate (a statistic) of 50%, given a binomial distribution.

Three physician specialties (nephrology, pathology, and radiology) were not included because they do not tend to prescribe opioids. All physician assistant and nurse practitioner specialties were sampled. A minimum quota of 50 respondents was set for the following five physician specialties due to their higher likelihood to prescribe opioids, with the following results:  anesthesiology (n=98), emergency medicine (n=109), general practice/internal medicine/family practice/primary care (n=77), neurology (n=70), and psychiatry (n=115). Surgeons (general, plastic, orthopedic, and neuro-), while not given a minimum quota, were sampled fairly heavily, again due to higher likelihood to prescribe opioids (n=60).

About Medscape and WebMD
Medscape is the leading source of clinical news, health information and point-of-care tools for healthcare professionals. Medscape offers specialists, primary care physicians and other health professionals the most robust and integrated medical information and educational tools. Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty focused destinations offering thousands of free C.M.E. and C.E. courses and other educational programs for physicians, nurses and other healthcare professionals.

WebMD Health Corp. (NASDAQ: WBMD) is the leading provider of health information services, serving consumers, physicians, healthcare professionals, employers, and health plans through our public and private online portals, mobile platforms and health-focused publications.

The WebMD Health Network includes WebMD Health, Medscape, MedicineNet, eMedicineHealth, RxList, Medscape Education and other owned WebMD sites.

WebMD®, Medscape®, CME Circle®, Medpulse®, eMedicine®, MedicineNet®, theheart.org® and RxList® are among the trademarks of WebMD Health Corp. or its subsidiaries.

Video - http://origin-qps.onstreammedia.com/origin/multivu_archive/PRNA/ENR/319078-Opioid-Misuse-and-Addiction.mp4
Logo - http://photos.prnewswire.com/prnh/20150811/257757LOGO
Logo - http://photos.prnewswire.com/prnh/20151110/286098LOGO

SOURCE WebMD

Related Links

http://www.webmd.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.